A small portion of these patients with a high inhaled corticosteroid (ICS) dosage will continue use of a second medication to keep their asthma under control, according to study findings. A study that ...
NSAID-exacerbated respiratory disease, N-ERD, is associated with measurable changes in concentrations of lipid mediators involved in inflammation and pain modulation, a new study shows. Plasma ...
NSAID-exacerbated respiratory disease, N-ERD, is associated with measurable changes in concentrations of lipid mediators involved in inflammation and pain modulation, a new study shows. Plasma ...
Please provide your email address to receive an email when new articles are posted on . Following 6 months of dupilumab treatment, 57% of patients with NSAID-exacerbated respiratory disease had higher ...
Nonsteroidal anti-inflammatory drug–exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results